The B cell-stimulatory cytokines BLyS and April are elevated in human periodontitis and are required for b cell-dependent bone loss in experimental murine periodontitis

Journal of Immunology

Volumn 195, Issue 4, 2015, Pages 1427-1435

  Abe, Toshiharu ^a   AlSarhan, Mohammed ^a,c   Benakanakere, Manjunatha R ^a   Maekawa, Tomoki ^a   Kinane, Denis F ^a   Cancro, Michael P ^b   Korostoff, Jonathan M ^a   Hajishengallis, George ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN KAPPA CHAIN; MESSENGER RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL GROWTH; CELL MATURATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MALE; MIDDLE AGED; MOUSE; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; UPREGULATION; WILD TYPE; AGED; ALVEOLAR BONE LOSS; ANIMAL; CASE CONTROL STUDY; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PLASMA CELL;

ADULT; AGED; ALVEOLAR BONE LOSS; ANIMALS; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PERIODONTITIS; PLASMA CELLS; RNA, MESSENGER; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84938922445     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500496     Document Type: Article

References (55)

1. Hajishengallis, G. 2015. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15: 30-44.
2. Lamont, R. J., and G. Hajishengallis. 2015. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol. Med. 21: 172-183.
3. Hajishengallis, G. 2014. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35: 3-11.
4. Garlet, G. P. 2010. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J. Dent. Res. 89: 1349-1363.
5. Gemmell, E., K. Yamazaki, and G. J. Seymour. 2007. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 2000 43: 14-40.
6. Graves, D. 2008. Cytokines that promote periodontal tissue destruction. J. Periodontol. 79(8, Suppl.): 1585-1591.
7. Page, R. C., and H. E. Schroeder. 1976. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab. Invest. 34: 235-249.
8. Thorbert-Mros, S., L. Larsson, and T. Berglundh. 2014. Cellular composition of long-standing gingivitis and periodontitis lesions. J. Periodontal Res. DOI: 10.1111/jre.12236.
9. Berglundh, T., M. Donati, and N. Zitzmann. 2007. B cells in periodontitis: friends or enemies? Periodontol. 2000 45: 51-66.
10. Schenkein, H. A. 2006. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol. 2000 40: 77-93.
11. Whitney, C., J. Ant, B. Moncla, B. Johnson, R. C. Page, and D. Engel. 1992. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect. Immun. 60: 2194-2200.
12. Nikolopoulou-Papaconstantinou, A. A., A. C. Johannessen, and T. Kristoffersen. 1987. Deposits of immunoglobulins, complement, and immune complexes in inflamed human gingiva. Acta Odontol. Scand. 45: 187-193.
13. Toto, P. D., L. M. Lin, and A. W. Gargiulo. 1978. Immunoglobulins and complement in human periodontitis. J. Periodontol. 49: 631-634.
14. Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N. Y. Karimbux, R. B. Goncalves, P. Valverde, S. Dibart, Y. P. Li, et al. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 169: 987-998.
15. Nakashima, T., M. Hayashi, and H. Takayanagi. 2012. New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol. Metab. 23: 582-590.
16. Harada, Y., X. Han, K. Yamashita, T. Kawai, J. W. Eastcott, D. J. Smith, and M. A. Taubman. 2006. Effect of adoptive transfer of antigen-specific B cells on periodontal bone resorption. J. Periodontal Res. 41: 101-107.
17. Han, X., T. Kawai, J. W. Eastcott, and M. A. Taubman. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J. Immunol. 176: 625-631.
18. Zhu, M., A. C. Belkina, J. DeFuria, J. D. Carr, T. E. Van Dyke, R. Gyurko, and B. S. Nikolajczyk. 2014. B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J. Leukoc. Biol. 96: 349-357.
19. Oliver-Bell, J., J. P. Butcher, J. Malcolm, M. K. MacLeod, A. Adrados Planell, L. Campbell, R. J. Nibbs, P. Garside, I. B. McInnes, and S. Culshaw. 2015. Periodontitis in the absence of B cells and specific anti-bacterial antibody. Mol. Oral Microbiol. 30: 160-169.
20. Mackay, F., P. Schneider, P. Rennert, and J. Browning. 2003. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21: 231-264.
21. Cancro, M. P. 2009. Signalling crosstalk in B cells: managing worth and need. Nat. Rev. Immunol. 9: 657-661.
22. López-Fraga, M., R. Fernández, J. P. Albar, and M. Hahne. 2001. Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep. 2: 945-951.
23. Vincent, F. B., E. F. Morand, P. Schneider, and F. Mackay. 2014. The BAFF/APRIL system in SLE pathogenesis. Nat. Rev. Rheumatol. 10: 365-373.
24. Huard, B., T. McKee, C. Bosshard, S. Durual, T. Matthes, S. Myit, O. Donze, C. Frossard, C. Chizzolini, C. Favre, et al. 2008. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J. Clin. Invest. 118: 2887-2895.
25. Gross, J. A., S. R. Dillon, S. Mudri, J. Johnston, A. Littau, R. Roque, M. Rixon, O. Schou, K. P. Foley, H. Haugen, et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15: 289-302.
26. Rickert, R. C., J. Jellusova, and A. V. Miletic. 2011. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol. Rev. 244: 115-133.
27. Hajishengallis, G., R. J. Lamont, and D. T. Graves. 2015. The enduring importance of animal models in understanding periodontal disease. Virulence 6: 229-235.
28. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
29. Damek-Poprawa, M., J. Korostoff, R. Gill, and J. M. DiRienzo. 2013. Cell junction remodeling in gingival tissue exposed to a microbial toxin. J. Dent. Res. 92: 518-523.
30. Weiss, L. M., S. Loera, and C. E. Bacchi. 2010. Immunoglobulin light chain immunohistochemistry revisited, with emphasis on reactive follicular hyperplasia versus follicular lymphoma. Appl. Immunohistochem. Mol. Morphol. 18: 199-205.
31. Graves, D. T., D. Fine, Y. T. Teng, T. E. Van Dyke, and G. Hajishengallis. 2008. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J. Clin. Periodontol. 35: 89-105.
32. Jiao, Y., Y. Darzi, K. Tawaratsumida, J. T. Marchesan, M. Hasegawa, H. Moon, G. Y. Chen, G. Núñez, W. V. Giannobile, J. Raes, and N. Inohara. 2013. Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity. Cell Host Microbe 13: 595-601.
33. Abe, T., and G. Hajishengallis. 2013. Optimization of the ligature-induced periodontitis model in mice. J. Immunol. Methods 394: 49-54.
34. Eskan, M. A., R. Jotwani, T. Abe, J. Chmelar, J. H. Lim, S. Liang, P. A. Ciero, J. L. Krauss, F. Li, M. Rauner, et al. 2012. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat. Immunol. 13: 465-473.
35. Abe, T., K. B. Hosur, E. Hajishengallis, E. S. Reis, D. Ricklin, J. D. Lambris, and G. Hajishengallis. 2012. Local complement-targeted intervention in periodontitis: proofof-concept using a C5a receptor (CD88) antagonist. J. Immunol. 189: 5442-5448.
36. Belibasakis, G. N., and N. Bostanci. 2012. The RANKL-OPG system in clinical periodontology. J. Clin. Periodontol. 39: 239-248.
37. Lappin, D. F., O. Koulouri, M. Radvar, P. Hodge, and D. F. Kinane. 1999. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. J. Clin. Periodontol. 26: 183-189.
38. Magro, C., A. N. Crowson, P. Porcu, and G. J. Nuovo. 2003. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application. J. Cutan. Pathol. 30: 504-511.
39. Maekawa, T., T. Abe, E. Hajishengallis, K. B. Hosur, R. A. DeAngelis, D. Ricklin, J. D. Lambris, and G. Hajishengallis. 2014. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. J. Immunol. 192: 6020-6027.
40. Carroll, M. C., and D. E. Isenman. 2012. Regulation of humoral immunity by complement. Immunity 37: 199-207.
41. Chen-Kiang, S. 1995. Regulation of terminal differentiation of human B-cells by IL-6. Curr. Top. Microbiol. Immunol. 194: 189-198.
42. Abe, T., J. Shin, K. Hosur, M. C. Udey, T. Chavakis, and G. Hajishengallis. 2014. Regulation of osteoclast homeostasis and inflammatory bone loss by MFG-E8. J. Immunol. 193: 1383-1391.
43. He, B., W. Xu, P. A. Santini, A. D. Polydorides, A. Chiu, J. Estrella, M. Shan, A. Chadburn, V. Villanacci, A. Plebani, et al. 2007. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelialcell secretion of the cytokine APRIL. Immunity 26: 812-826.
44. Gümüş, P., N. Nizam, D. F. Lappin, and N. Buduneli. 2014. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-A in patients with periodontitis. J. Periodontol. 85: 270-280.
45. Scapini, P., Y. Hu, C. L. Chu, T. S. Migone, A. L. Defranco, M. A. Cassatella, and C. A. Lowell. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207: 1757-1773.
46. Miossec, P., and J. K. Kolls. 2012. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11: 763-776.
47. Scapini, P., B. Nardelli, G. Nadali, F. Calzetti, G. Pizzolo, C. Montecucco, and M. A. Cassatella. 2003. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197: 297-302.
48. Scapini, P., A. Carletto, B. Nardelli, F. Calzetti, V. Roschke, F. Merigo, N. Tamassia, S. Pieropan, D. Biasi, A. Sbarbati, et al. 2005. Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases. Blood 105: 830-837.
49. Hajishengallis, G., T. Abe, T. Maekawa, E. Hajishengallis, and J. D. Lambris. 2013. Role of complement in host-microbe homeostasis of the periodontium. Semin. Immunol. 25: 65-72.
50. Kajiya, M., G. Giro, M. A. Taubman, X. Han, M. P. Mayer, and T. Kawai. 2010. Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease. J. Oral Microbiol. 2: 5532. DOI: 10.3402/jom.v2i0.5532.
51. Kleinfelder, J. W., D. E. Lange, and W. Böcker. 2000. Some effects of nonsurgical therapy on gingival inflammatory cell subsets in patients with adult and early-onset periodontitis. J. Periodontol. 71: 1561-1566.
52. Gümüş, P., E. Buduneli, B. Biyikoglu, K. Aksu, F. Saraç, N. Buduneli, and D. F. Lappin. 2013. Gingival crevicular fluid and serum levels of APRIL, BAFF and TNF-alpha in rheumatoid arthritis and osteoporosis patients with periodontal disease. Arch. Oral Biol. 58: 1302-1308.
53. Page, R. C., and H. E. Schroeder. 1982. Periodontitis in Man and Other Animals: A Comparative Review. Karger, Basel, Switzerland.
54. La Cava, A. 2013. Targeting the BLyS-APRIL signaling pathway in SLE. Clin. Immunol. 148: 322-327.
55. Ding, H. J., and C. Gordon. 2013. New biologic therapy for systemic lupus erythematosus. Curr. Opin. Pharmacol. 13: 405-412.